Home Blood Pressure and Preclinical Organ Damage

Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


We reviewed the literature regarding current evidence about associations between home blood pressure (BP) and preclinical target organ damage. Previous studies have identified associations between home BP values and various types of preclinical target organ damage, such as left ventricular hypertrophy (LVH), carotid atherosclerosis including carotid intima-media thickness and carotid plaque, renal function including urinary protein excretion and glomerular filtration rate, and pulse wave velocity or silent cerebrovascular lesions. Although the strength of these associations has been compared between home and conventional office BP values, and a closer association between home BP and LVH has been established, the findings are inconsistent and/or limited to identifying a closer association between home BP and preclinical organ damage other than LVH. Masked hypertension (MHT) is a subtype of hypertension characterized by BP values not showing hypertension in the office but being in the hypertensive range when measured out of the office. Few studies have examined the association between MHT determined by self-measured BP at home and preclinical target organ damage. Nonetheless, all of them identified significantly higher risk of preclinical target organ damage in patients with MHT than in individuals with normal BP values. These findings altogether indicate that individuals with advanced preclinical target organ damage and normal office BP values should measure their BP at home for the early detection of MHT.


Hypertension Blood pressure measurement Home blood pressure Preclinical target organ damage Masked hypertension 


  1. 1.
    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.PubMedGoogle Scholar
  2. 2.
    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRefGoogle Scholar
  3. 3.
    Bliziotis I, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30(7):1289–99.CrossRefGoogle Scholar
  4. 4.
    Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension. 2011;57(6):1087–93.CrossRefGoogle Scholar
  5. 5.
    Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Japan morning surge-home blood pressure study investigators group. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60(4):921–8.CrossRefGoogle Scholar
  6. 6.
    Her AY, Kim YH, Rim SJ, Kim JY, Choi EY, Min PK, Lee BK, Hong BK, Kwon HM. Home blood pressure is the predictor of subclinical target organ damage like ambulatory blood pressure monitoring in untreated hypertensive patients. Anadolu Kardiyol Derg. 2014;14(8):711–8.CrossRefGoogle Scholar
  7. 7.
    Lin TT, Juang JJ, Lee JK, Tsai CT, Chen CH, Yu WC, et al. Comparison of home and ambulatory blood pressure measurements in association with preclinical hypertensive cardiovascular damage. J Cardiovasc Nurs. 2019;34(2):106–14.CrossRefGoogle Scholar
  8. 8.
    Siven SS, Niiranen TJ, Langen VL, Puukka PJ, Kantola IM, Jula AM. Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study. J Hypertens. 2017;35(2):266–71.CrossRefGoogle Scholar
  9. 9.
    Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE study group. Study on ambulatory monitoring of blood pressure and Lisinopril evaluation. Circulation. 1997;95(6):1464–70.CrossRefGoogle Scholar
  10. 10.
    Martínez MA, Sancho T, García P, Moreno P, Rubio JM, Palau FJ, et al. Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage. Blood Press Monit. 2006;11(4):207–13.CrossRefGoogle Scholar
  11. 11.
    Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens. 2008;26(10):1919–27.CrossRefGoogle Scholar
  12. 12.
    Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27(9):633–9.CrossRefGoogle Scholar
  13. 13.
    Niiranen T, Jula A, Kantola I, Moilanen L, Kähönen M, Kesäniemi YA, et al. Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME study. J Hypertens. 2007;25(6):1225–31.CrossRefGoogle Scholar
  14. 14.
    Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, Metoki H, et al. Ambulatory versus home versus clinic blood pressure: the association with subclinical cerebrovascular diseases: the Ohasama study. Hypertension. 2012;59(1):22–8.CrossRefGoogle Scholar
  15. 15.
    Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20(6):616–21.CrossRefGoogle Scholar
  16. 16.
    Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, et al. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1. Hypertens Res. 2009;32(9):770–4.CrossRefGoogle Scholar
  17. 17.
    Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Tokudome G, Hosoya T. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy. Intern Med. 2005;44(12):1239–46.CrossRefGoogle Scholar
  18. 18.
    Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, et al. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease. Hypertens Res. 2009;32(12):1123–9.CrossRefGoogle Scholar
  19. 19.
    Calvo-Vargas C, Padilla-Rios V, Meza-Flores A, Vazquez-Linares G, Troyo-Sanromán R, Cerda AP, et al. Arterial stiffness and blood pressure self-measurement with loaned equipment. Am J Hypertens. 2003;16(5 Pt 1):375–80.CrossRefGoogle Scholar
  20. 20.
    Niiranen TJ, Jula AM, Kantola IM, Kähönen M, Reunanen A. Home blood pressure has a stronger association with arterial stiffness than clinic blood pressure: the Finn-Home Study. Blood Press Monit. 2009;14(5):196–201.CrossRefGoogle Scholar
  21. 21.
    Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis. Am J Hypertens. 2015;28(6):806–13.CrossRefGoogle Scholar
  22. 22.
    Hara A, Ohkubo T, Kikuya M, Shintani Y, Obara T, Metoki H, et al. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens. 2007;25(2):321–7.CrossRefGoogle Scholar
  23. 23.
    Hara A, Ohkubo T, Kondo T, Kikuya M, Aono Y, Hanawa S, et al. Detection of silent cerebrovascular lesions in individuals with ‘masked’ and ‘white-coat’ hypertension by home blood pressure measurement: the Ohasama study. J Hypertens. 2009;27(5):1049–55.CrossRefGoogle Scholar
  24. 24.
    Terawaki H, Metoki H, Nakayama M, Ohkubo T, Kikuya M, Asayama K, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res. 2008;31(12):2129–35.CrossRefGoogle Scholar
  25. 25.
    Hanninen MR, Niiranen TJ, Puukka PJ, Kesaniemi YA, Kahonen M, Jula AM. Target organ damage and masked hypertension in the general population: the Finn-home study. J Hypertens. 2013;31(6):1136–43.CrossRefGoogle Scholar
  26. 26.
    Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, et al. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study. Stroke. 2013;44(6):1512–7.CrossRefGoogle Scholar
  27. 27.
    Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, et al. White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama study. Hypertens Res. 2017;40(11):937–43.CrossRefGoogle Scholar
  28. 28.
    Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens. 2007;20(4):385–91.CrossRefGoogle Scholar
  29. 29.
    Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66(20):2159–69.CrossRefGoogle Scholar
  30. 30.
    Hoshide S, Kario K, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, et al. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP study. Am J Hypertens. 2014;27(7):939–47.CrossRefGoogle Scholar
  31. 31.
    Sakata S, Hata J, Fukuhara M, Yonemoto K, Mukai N, Yoshida D, et al. Morning and evening blood pressures are associated with intima-media thickness in a general population- the Hisayama study. Circ J. 2017;81(11):1647–53.CrossRefGoogle Scholar
  32. 32.
    Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Optimal schedule for home blood pressure monitoring based on a clinical approach. J Hypertens. 2010;28(2):259–64.CrossRefGoogle Scholar

Copyright information

© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of Hygiene and Public HealthTeikyo University School of MedicineTokyoJapan
  2. 2.Tohoku Institute for Management of Blood PressureSendaiJapan
  3. 3.Division of Cardiovascular Medicine, Department of MedicineJichi Medical University School of Medicine (JMU)TochigiJapan
  4. 4.Department of Public Health SolutionsNational Institute for Health and WelfareTurkuFinland
  5. 5.Department of MedicineTurku University Hospital and University of TurkuTurkuFinland
  6. 6.Department of MedicineColumbia University Medical CenterNew YorkUSA
  7. 7.University of Milano-BicoccaMilanItaly

Personalised recommendations